SCHEMBL20173079

SCHEMBL20173079

c1ccc(N(c2ccccc2)c2ccc(-c3ccc4c(c3)-c3ccccc3C43c4ccccc4-c4cc5c6ccccc6c6ccccc6c5cc43)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PDK2 Q15119 6/20 0.34
MEN1 O00255 2/20 0.31
LMNA P02545 2/20 0.31
KMT2A Q03164 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
OPRK1 P41145 1/20 0.31
APAF1 O14727 1/20 0.30
NPC1 O15118 1/20 0.30
THRB P10828 1/20 0.30
XBP1 P17861 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20172946 0.95 PDK2 (0.40) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL18659283 0.93 KDM4E (0.33) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL18659381 0.93 KDM4E (0.33) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL20172950 0.93 PDK2 (0.42) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL18659184 0.92 PDK2 (0.34) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL20172969 0.92 PDK2 (0.43) MAPTL3MBTL1PDK2MEN1LMNA
SCHEMBL18659284 0.92 PDK2 (0.34) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL17929498 0.92 PDK2 (0.34) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL20218367 0.92 MAPT (0.34) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2
SCHEMBL18659369 0.91 PDK2 (0.36) MAPTKDM4EL3MBTL1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10651411-B2 Compound and organic light emitting device containing same LG CHEM, LTD. (KR) 2020-05-12 US disclosed
US-20180145272-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180145272-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180145272-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME CRY1, CRY2, OR10J3 MAPT 754/4885KDM4E 1258/4885L3MBTL1 349/4885
US-10651411-B2 Compound and organic light emitting device containing same CRY1, CRY2, OR10J3 MAPT 754/4885KDM4E 1258/4885L3MBTL1 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.